Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New developments in pancreatic cancer.

G G Ginsberg1

  • 1Gastroenterology Division, University of Pennsylvania Health Systems, Hospital of the University of Pennsylvania, Philadelphia 19104, USA.

Seminars in Gastrointestinal Disease
|August 19, 2000
PubMed
Summary

Pancreatic adenocarcinoma is a leading cause of cancer death. Early detection and surgical resection offer the best prognosis, but survival rates remain low for most patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A large multicenter cohort on the use of full-thickness resection device for difficult colonic lesions.

Surgical endoscopy·2020
Same author

Adherence to the 2011 American Gastroenterological Association medical position statement for the diagnosis and management of Barrett's esophagus.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2014
Same author

Endoscopic retrograde cholangiopancreatography.

Endoscopy·2007
Same author

Case report: ectopic pancreatic rest in the proximal stomach mimicking gastric neoplasms.

Clinical radiology·2007
Same author

Relationship between intragastric acid control and healing status in the treatment of moderate to severe erosive oesophagitis.

Alimentary pharmacology & therapeutics·2007
Same author

Multicenter comparative trial of the V-scope system for therapeutic ERCP.

Endoscopy·2006

Area of Science:

  • Oncology
  • Gastroenterology

Background:

  • Pancreatic adenocarcinoma is the fifth leading cause of cancer mortality in the U.S.
  • Affects men and women equally, typically diagnosed in older adults.
  • Risk factors include hereditary pancreatitis and smoking.

Observation:

  • Often presents with painless jaundice due to biliary obstruction, commonly originating in the pancreatic head.
  • Pancreatic computed tomography (CT) is the primary diagnostic tool.
  • Endoscopic retrograde cholangiopancreatography (ERCP) is used for tissue sampling and palliative stenting.

Findings:

  • Surgical resection (Whipple procedure) offers the only curative option.
  • Resectable disease, defined by absence of metastasis and major vessel involvement, has a 5-year survival rate of approximately 10%.
  • Median survival is 12-18 months for resectable and 6 months for unresectable cases.

Implications:

  • Adjuvant chemotherapy (5-FU, gemcitabine) offers modest survival benefits.
  • Palliative care focuses on biliary decompression, pain management, and gastric drainage.
  • Improved diagnostic and therapeutic strategies are crucial for enhancing patient outcomes in pancreatic cancer.

Related Experiment Videos